Wednesday 21 February 2018

Neuroendoscopy devices market Expected to reach USD 203.9 million by 2025 : Grand View Research, Inc.


The global neuroendoscopydevices market is expected to reach USD 203.9 million by 2025, according to a new report by Grand View Research, Inc. Demand for neuroendoscopy is increasing due to global rise in number of brain tumor cases and growing adoption of minimally invasive surgical procedures.  
Conventional surgical procedures of brain such as craniotomy is invasive which includes opening of the skull of the patient. This increases the risk of associated conditions such as stroke or hemorrhage, blindness, deafness and in some cases death. Such high risks associated with the conventional surgical procedures of brain are resulting in replacement by adoption of minimally invasive endoscopic procedures.  In addition, increasing cases of pituitary tumors and increasing prevalence of brain cancer is supporting the growth of the market. Few companies engaged in neuroendoscopy manufacturing are B. Braun Medical Inc., Karl Storz, Olympus Corporation, Zeiss International, Stryker, and Medtronic
Full research report on neuroendoscopy devices market analysis: https://www.grandviewresearch.com/industry-analysis/neuroendoscopy-market

Further Key Findings from the Study Suggest:
·         Rise in the brain injuries, and neural surgeries coupled with adoption of minimally invasive procedures is driving the growth of the market
·         Intraventricular segment accounted for the largest revenue share in 2016 mainly due to constantly increasing incidences of the intraventricular hemorrhage and bleeding
·         Transcranial surgery segment is expected to grow at the fastest growth rate owing to the factors such as increasing cases of pituitary gland tumors and technological advancements
·         Rigid neuroendoscopes being light weight and small in size are preferred over flexible ones. However, flexible endoscopes segment is expected to grow at the fastest growth rate during the forecast period.
·         Maximum number of neuro-endoscopic procedures are performed in hospitals. Thus, the segment accounted for the largest revenue share in 2016 and is anticipated to remain dominant throughout the forecast period.
·         North America and Europe dominated the market together in 2016. Availability of advanced healthcare infrastructure and high adoption of advanced techniques are some of the prime factors resulting in the highest adoption of neuroendoscopy procedures in these regions.  
·         Key players in the market include B. Braun Medical Inc., Karl Storz, Olympus Corporation, Zeiss International, Stryker, and Medtronic.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented neuroendoscopy devices market report on the basis of surgery type, application, device type, and region:
Neuroendoscopy Devices Surgery Type Outlook (Revenue, USD Million; 2014 - 2025)
·         Intraventricular
·         Transcranial
·         Transnasal
Neuroendoscopy Devices Type Outlook (Revenue, USD Million; 2014 - 2025)
·         Rigid
·         Flexible
Neuroendoscopy Devices Application Outlook (Revenue, USD Million; 2014 - 2025)
·         Hospitals
·         Medical Research Centers
Neuroendoscopy Devices Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/

Intrapartum monitoring devices market expected to reach USD 2.83 billion by 2025 : Grand View Research, Inc.


The global intrapartummonitoring devices market is expected to reach USD 2.83 billion by 2025, according to a new report by Grand View Research, Inc. The rising occurrences of preterm birth are resulting in increased infant mortality. The mortality rates differ across the globe, owing to the disparities of income, and lack of access to appropriate maternal care facilities in different regions. The regions with larger lower income groups face the highest infant mortality rates due to inadequate availability of obstetric monitoring and other infant care facilities. Effective maternal and postnatal care can help save more than 3 quarters of the premature babies.
According to the reports of WHO, annually 15.0 million infants are born premature. This number has been observed to be on a rise in the past few years. There are multiple causes for premature deliveries, such as high blood pressure, chronic conditions, infections, multiple pregnancies, early induction of labor. Hence, propelling the need for obstetric devices across the globe.
Rising awareness regarding availability of screening and monitoring procedures, growing prevalence of obesity & Gestational   Diabetes Mellitus (GDM) and increasing demand for improved intrapartum devices are expected to propel the market over the forecast period. 

Full research report on intrapartum monitoring devices market analysis: https://www.grandviewresearch.com/industry-analysis/intrapartum-monitors-market

Further key findings from the study suggest:
·         The growing prevalence of obesity, rising preterm birth rate and increasing need for critical obstetric care is primarily driving the market growth
·         The electrodes dominated the market, owing to their affordability, higher adoption volume and repeat purchase.
·         The monitors segment is expected to exhibit fastest growth over the forecast period owing to the technological advancements.
·         North America dominated the market in 2016, owing to rising prevalence of obesity and diabetes, various government initiatives creating awareness regarding rising incidences of preterm births, availability of monitoring test options, and highly developed healthcare infrastructure.
·         Constant rise in the cases of preterm births and infant mortality rates are observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
·         The key players of the market include Analogic Corporation, GE Healthcare, Koninklijke Philips N.V.; Medtronic plc; CooperSurgical, Inc.; Stryker, and Olympus Corporation.
·         These players hold a strong position in market with their strategic initiatives such as mergers and acquisitions, partnerships with small/local players to expand their geographic foothold and widening of product portfolio by sharing the technology and products.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the intrapartum monitoring devices market report on the basis of device type and region:
Device Type Outlook (Revenue, USD Million; 2014 - 2025)
·         Monitors
·         Electrodes
o    Fetal Scalp Electrodes
o    Intrauterine Pressure Catheter
o    Transducer for FHR
o    Transducer for Uterine Contractions
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/


Tuesday 20 February 2018

Agrochemicals market expected to reach USD 308.92 billion by 2025 : Grand View Research, Inc.


The global agrochemicals market is expected to reach USD 308.92 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for crop protection chemicals, such as fungicides, herbicides, and insecticides, is expected to be the biggest driver of the agrochemicals industry over the forecast period.  
Shrinking arable land due to rapid industrialization and population explosion has resulted in increased use of agrochemicals, such as fertilizers and plant growth regulators, further triggering the market growth. The growing demand for crops as animal fodder and fiber in the textile industry has also provided the necessary boost to the agrochemicals industry.
Fertilizers dominated the agrochemicals market in 2016. Nitrogenous and phosphate fertilizers were most widely used due to their easy availability and low prices. However, the new trend of organic farming, which involves complete elimination of chemical-based fertilizers, has increased the demand for biofertilizers.
The demand for agrochemicals is expected to be the highest in Asia Pacific. The region is known for its agro-based countries such as India, Sri Lanka, and China, which are majorly dependent on agriculture and related industries for economic growth.
Full research report on agrochemicals market analysis: http://www.grandviewresearch.com/industry-analysis/agrochemicals-market

Further key findings from the report suggest:
·         The global agrochemicals market, in terms of value, was USD 215.18 billion in 2016 and is projected to reach USD 308.92 billion by 2025, growing at a CAGR of 4.1% from 2017 to 2025
·         Fertilizers, which accounted for 58.8% of the market in 2016, in terms of revenue, are expected to witness growth on account of increasing pressure on agricultural land to increase yield in a short time span
·         Crop protection chemicals, in terms of revenue, are expected to grow at a CAGR of 5.5% from 2017 to 2025 due to rising occurrences of pest and rodent attacks damaging crops
·         The market for agrochemicals in cereals & grains was valued at USD 80.01 billion in 2016. The application segment is expected to grow owing to an increase in the demand for whole grain products.
·         Oilseeds & pulses, which are considered to have high protein content, are projected to grow at the highest CAGR of 4.9%, in terms of value, from 2017 to 2025
·         The market in Asia Pacific is expected to witness the highest growth over the forecast period due to the growing agro-based industries including sugar, textiles, vegetable oil manufacturing, and animal husbandry
·         Bayer CropScience, Agrium, and Yara International were some of the key manufacturers in 2016 with distribution facilities spread across all regions
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers
Grand View Research has segmented the global agrochemicals market on the basis of product, application, and region:
Agrochemicals Product Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)
·         Fertilizers
·         Crop Protection Chemicals
·         Plant Growth Regulators
·         Others
Agrochemicals Application Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)
·         Cereals & Grains
·         Oilseeds & Pulses
·         Fruits & Vegetables
·         Others
Agrochemicals Regional Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)
·         North America
o    U.S.
·         Europe
o    Germany
o    Spain
·         Asia Pacific
o    China
o    India
·         Central & South America
o    Brazil
·         Middle East & Africa 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com


Antipsychotic drugs market expected to reach USD 14.4 billion by 2025 : Grand View Research, Inc.


The global antipsychotic drugs market is expected to reach USD 14.4 billion by 2025, according to a new report by Grand View Research, Inc. The continuous development of better next-generation products to overcome adverse effects and unwanted reactions of existing products is creating demand for newer products. This factor is anticipated to propel the market.
Rapid growth of antipsychotics can be attributed to the rising prevalence of psychosis and other mental disorders. Governments are focused on creating awareness regarding mental health and psychological illnesses, which is further anticipated to drive the demand for antipsychotics. Government bodies in collaboration with major players conduct social programs to break the stigma related to psychotic disorders that exists in the society.
Adverse effects of antipsychotics, such as insomnia, dry mouth, drowsiness, and blurred vision, are expected to affect the growth by decreasing the level of acceptance in patients. In addition, the possibility of dependency, habit formation, or addiction is affecting the adoption of these drugs.
Established brands such as, Zyprexa lost patent protection in October 2011, followed by Seroquel and Risperdal in 2012, which hampers the market growth for these drugs. Also, the entry of generic versions of these products slowed the growth of the already existing brands.
Full research report on antipsychotic drugs market analysis: http://www.grandviewresearch.com/industry-analysis/antipsychotic-drugs-market

Further Key Findings From the Study Suggest:
·         The growing prevalence of mental disorders, increased investments on R&D, and rising awareness regarding these conditions are augmenting the growth of the market.
·         The first-generation of antipsychotics have serious adverse effects and are very rarely used, hence they hold negligible share in the market.
·         The second-generation segment of drugs accounted for the largest share in 2015 and are anticipated to further expand during the forecast period despite the adverse effects
·         As of January 2016, the third-generation segment has only one approved product, Abilify. It has negligible adverse effects and is expected to be the fastest growing segment over the forecast period
·         In 2015, North America dominated the global space with the largest revenue share owing to rising prevalence of mental illnesses
·         Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding mental disorders and improving access to treatment
·         Some of the major players in this market are Johnson & Johnson; Pfizer, Inc.; Eli Lilly & Co.; and Bristol-Myers Squibb

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the antipsychotic drugs market by drug class, application, and region:
Antipsychotics Drug Class Outlook (Revenue, USD Million; 2014 - 2025)
·         First Generation
·         Second Generation
·         Third Generation
Antipsychotics Application Outlook (Revenue, USD Million; 2014 - 2025)
·         Schizophrenia
·         Bipolar disorder
·         Unipolar depression
·         Dementia
·         Others
Antipsychotics Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com